Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.

Literature DB >> 21990402

Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.

Joo Y Song¹, Ted Strom, Mark Raffeld, Stefania Pittaluga, Elaine S Jaffe.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21990402 PMCID： PMC3221531 DOI： 10.1200/JCO.2011.36.9280

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
References

× No keyword cloud information.

8 in total

1. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified.

Authors: Yuji Hirata; Taiji Yokote; Kichinosuke Kobayashi; Shoko Nakayama; Takuji Miyoshi; Toshikazu Akioka; Satoshi Hara; Motomu Tsuji; Takayuki Takubo; Toshiaki Hanafusa
Journal: Leuk Res Date: 2008-11-07 Impact factor: 3.156

2. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.

Authors: X Yao; J Teruya-Feldstein; M Raffeld; L Sorbara; E S Jaffe
Journal: Mod Pathol Date: 2001-02 Impact factor: 7.842

3. Rare expression of T-cell markers in classical Hodgkin's lymphoma.

Authors: Alexandar Tzankov; Caroline Bourgau; Alexandra Kaiser; Annette Zimpfer; Robert Maurer; Stefano A Pileri; Philip Went; Stephan Dirnhofer
Journal: Mod Pathol Date: 2005-12 Impact factor: 7.842

4. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.

Authors: K Blakolmer; M Vesely; J A Kummer; W Jurecka; C Mannhalter; A Chott
Journal: Mod Pathol Date: 2000-07 Impact factor: 7.842

5. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.

Authors: L Quintanilla-Martinez; F Fend; L R Moguel; L Spilove; M W Beaty; D W Kingma; M Raffeld; E S Jaffe
Journal: Am J Surg Pathol Date: 1999-10 Impact factor: 6.394

Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.

1. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified.

2. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.

3. Rare expression of T-cell markers in classical Hodgkin's lymphoma.

4. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.

5. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.

6. Peripheral T-cell lymphomas expressing CD30 and CD15.

7. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.

8. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.